These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23312056)

  • 1. Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.
    Sever S; Weinstein DA; Wolfsdorf JI; Gedik R; Schaefer EJ
    J Clin Lipidol; 2012; 6(6):596-600. PubMed ID: 23312056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenofibrate rapidly decreases hepatic lipid and glycogen storage in neonatal mice with glycogen storage disease type Ia.
    Yavarow ZA; Kang HR; Waskowicz LR; Bay BH; Young SP; Yen PM; Koeberl DD
    Hum Mol Genet; 2020 Jan; 29(2):286-294. PubMed ID: 31816064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements of hypertriglyceridemia and hyperlacticemia in Japanese children with glycogen storage disease type Ia by medium-chain triglyceride milk.
    Nagasaka H; Hirano K; Ohtake A; Miida T; Takatani T; Murayama K; Yorifuji T; Kobayashi K; Kanazawa M; Ogawa A; Takayanagi M
    Eur J Pediatr; 2007 Oct; 166(10):1009-16. PubMed ID: 17206455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired Very-Low-Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia.
    Hoogerland JA; Peeks F; Hijmans BS; Wolters JC; Kooijman S; Bos T; Bleeker A; van Dijk TH; Wolters H; Gerding A; van Eunen K; Havinga R; Pronk ACM; Rensen PCN; Mithieux G; Rajas F; Kuipers F; Reijngoud DJ; Derks TGJ; Oosterveer MH
    J Inherit Metab Dis; 2021 Jul; 44(4):879-892. PubMed ID: 33739445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperlipidemia and fatty acid composition in patients treated for type IA glycogen storage disease.
    Greene HL; Swift LL; Knapp HR
    J Pediatr; 1991 Sep; 119(3):398-403. PubMed ID: 1880653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings.
    Wolfsdorf JI; Keller RJ; Landy H; Crigler JF
    J Pediatr; 1990 Sep; 117(3):384-91. PubMed ID: 2202802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained high plasma mannose less sensitive to fluctuating blood glucose in glycogen storage disease type Ia children.
    Nagasaka H; Yorifuji T; Bandsma RH; Takatani T; Asano H; Mochizuki H; Takuwa M; Tsukahara H; Inui A; Tsunoda T; Komatsu H; Hiejima E; Fujisawa T; Hirano K; Miida T; Ohtake A; Taguchi T; Miwa I
    J Inherit Metab Dis; 2013 Jan; 36(1):75-81. PubMed ID: 22971957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control.
    Peeks F; Steunenberg TAH; de Boer F; Rubio-Gozalbo ME; Williams M; Burghard R; Rajas F; Oosterveer MH; Weinstein DA; Derks TGJ
    J Inherit Metab Dis; 2017 Sep; 40(5):695-702. PubMed ID: 28397058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis.
    Shah KK; O'Dell SD
    J Hum Nutr Diet; 2013 Aug; 26(4):329-39. PubMed ID: 23294025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid status and linear relationship between total cholesterol and triglycerides in glycogen storage disease type I.
    Zhang ZJ; Yuan YH; Ma MS; Hong YH; Sun ZX; Xu YW; Wei M; Qiu ZQ
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10036-10044. PubMed ID: 33090409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction of metabolic abnormalities in a mouse model of glycogen storage disease type Ia by CRISPR/Cas9-based gene editing.
    Arnaoutova I; Zhang L; Chen HD; Mansfield BC; Chou JY
    Mol Ther; 2021 Apr; 29(4):1602-1610. PubMed ID: 33359667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy.
    Parker P; Burr I; Slonim A; Ghishan FK; Greene H
    Gastroenterology; 1981 Sep; 81(3):534-6. PubMed ID: 6941908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular adenoma and metabolic balance in patients with type Ia glycogen storage disease.
    Di Rocco M; Calevo MG; Taro' M; Melis D; Allegri AE; Parenti G
    Mol Genet Metab; 2008 Apr; 93(4):398-402. PubMed ID: 18083610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cornstarch requirements of the adult glycogen storage disease Ia population: A retrospective review.
    Dahlberg KR; Ferrecchia IA; Dambska-Williams M; Resler TE; Ross KM; Butler GL; Kuo CL; Ryan PT; Weinstein DA
    J Inherit Metab Dis; 2020 Mar; 43(2):269-278. PubMed ID: 31415093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.
    Saeed A; Hoogerland JA; Wessel H; Heegsma J; Derks TGJ; van der Veer E; Mithieux G; Rajas F; Oosterveer MH; Faber KN
    Hum Mol Genet; 2020 Jan; 29(2):264-273. PubMed ID: 31813960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib.
    Correia CE; Bhattacharya K; Lee PJ; Shuster JJ; Theriaque DW; Shankar MN; Smit GP; Weinstein DA
    Am J Clin Nutr; 2008 Nov; 88(5):1272-6. PubMed ID: 18996862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
    Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
    Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal daytime feeding regimen to prevent postprandial hypoglycemia in type 1 glycogen storage disease.
    Wolfsdorf JI; Ehrlich S; Landy HS; Crigler JF
    Am J Clin Nutr; 1992 Sep; 56(3):587-92. PubMed ID: 1503073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An infant presenting with extreme hypertriglyceridemia diagnosed as glycogen storage disease type Ia.
    Fang LJ; Abuduxikuer K; Yan XM; Zhu H; Huang KY
    J Pediatr Endocrinol Metab; 2020 May; 33(6):803-808. PubMed ID: 32436859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.